ZNF182
gene geneOn this page
Also known as KOX14HHZ150Zfp182
Summary
ZNF182 (zinc finger protein 182, HGNC:13001) is a protein-coding gene on chromosome Xp11.23, encoding Zinc finger protein 182 (P17025). May be involved in transcriptional regulation.
Zinc-finger proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation, and apoptosis. This gene encodes a zinc finger protein, and belongs to the krueppel C2H2-type zinc-finger protein family. It may be involved in transcriptional regulation. Multiple alternatively spliced transcript variants encoding different isoforms have been identified.
Source: NCBI Gene 7569 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 44 total — 1 likely-pathogenic
- MANE Select transcript:
NM_001007088
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13001 |
| Approved symbol | ZNF182 |
| Name | zinc finger protein 182 |
| Location | Xp11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KOX14, HHZ150, Zfp182 |
| Ensembl gene | ENSG00000147118 |
| Ensembl biotype | protein_coding |
| OMIM | 314993 |
| Entrez | 7569 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 protein_coding
ENST00000376943, ENST00000396965, ENST00000897864, ENST00000897865, ENST00000934376, ENST00000934377, ENST00000960814
RefSeq mRNA: 3 — MANE Select: NM_001007088
NM_001007088, NM_001178099, NM_006962
CCDS: CCDS35235, CCDS35236
Canonical transcript exons
ENST00000376943 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001472203 | 47982949 | 47983038 |
| ENSE00001765627 | 47983285 | 47983411 |
| ENSE00001868952 | 48003909 | 48003989 |
| ENSE00001926044 | 47974851 | 47977797 |
| ENSE00003489846 | 48002595 | 48002653 |
| ENSE00003586340 | 48003508 | 48003702 |
Expression profiles
Bgee: expression breadth ubiquitous, 250 present calls, max score 93.05.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9201 / max 36.0833, expressed in 1464 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 199146 | 3.2513 | 1392 |
| 199148 | 0.4295 | 222 |
| 199147 | 0.2393 | 91 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 93.05 | gold quality |
| pancreatic ductal cell | CL:0002079 | 87.43 | silver quality |
| vena cava | UBERON:0004087 | 86.92 | silver quality |
| cerebellar vermis | UBERON:0004720 | 85.96 | silver quality |
| kidney epithelium | UBERON:0004819 | 85.77 | silver quality |
| thymus | UBERON:0002370 | 85.37 | gold quality |
| oocyte | CL:0000023 | 85.08 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 84.07 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 83.58 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 83.34 | gold quality |
| pylorus | UBERON:0001166 | 82.96 | gold quality |
| pericardium | UBERON:0002407 | 81.04 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 81.04 | gold quality |
| body of tongue | UBERON:0011876 | 80.96 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 80.94 | gold quality |
| cardia of stomach | UBERON:0001162 | 80.66 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 80.66 | gold quality |
| parotid gland | UBERON:0001831 | 80.63 | silver quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 80.47 | gold quality |
| heart right ventricle | UBERON:0002080 | 80.33 | gold quality |
| visceral pleura | UBERON:0002401 | 80.26 | gold quality |
| cerebellar cortex | UBERON:0002129 | 80.25 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 80.24 | gold quality |
| superior surface of tongue | UBERON:0007371 | 80.08 | gold quality |
| cerebellum | UBERON:0002037 | 80.02 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 79.92 | gold quality |
| tongue | UBERON:0001723 | 79.74 | gold quality |
| granulocyte | CL:0000094 | 79.59 | gold quality |
| pons | UBERON:0000988 | 79.52 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 79.07 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.86 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
43 targeting ZNF182, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-3912-5P | 99.95 | 66.11 | 925 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-2116-3P | 99.74 | 64.32 | 889 |
| HSA-MIR-1976 | 99.74 | 65.48 | 1127 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-6887-3P | 99.66 | 67.83 | 1778 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-497-3P | 99.61 | 69.71 | 1990 |
| HSA-MIR-488-3P | 99.61 | 68.79 | 1731 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-6733-3P | 99.54 | 67.80 | 1281 |
| HSA-MIR-549A-3P | 99.54 | 68.17 | 825 |
| HSA-MIR-143-3P | 99.49 | 69.05 | 1457 |
| HSA-MIR-4770 | 99.49 | 69.09 | 1451 |
| HSA-MIR-20A-3P | 99.44 | 69.10 | 1575 |
| HSA-MIR-520A-5P | 99.35 | 66.72 | 1632 |
| HSA-MIR-525-5P | 99.35 | 66.85 | 1615 |
| HSA-MIR-6088 | 99.29 | 68.45 | 1284 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp182 | ENSMUSG00000054737 |
| rattus_norvegicus | Zfp182 | ENSRNOG00000047132 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)
Protein
Protein identifiers
Zinc finger protein 182 — P17025 (reviewed: P17025)
Alternative names: Zinc finger protein 21, Zinc finger protein KOX14
All UniProt accessions (1): P17025
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P17025-1 | 1 | yes |
| P17025-2 | 2 |
RefSeq proteins (3): NP_001007089, NP_001171570, NP_008893 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050717 | C2H2-ZF_Transcription_Reg | Family |
Pfam: PF00096, PF01352
UniProt features (20 total): zinc finger region 15, chain 1, domain 1, region of interest 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P17025-F1 | 70.89 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 49 (showing top):
AAGTCCA_MIR422B_MIR422A, GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP, AAACCAC_MIR140, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, chrXp11, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, RAO_BOUND_BY_SALL4, BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ZNF274_TARGET_GENES, ZNF322_TARGET_GENES, ZNF350_TARGET_GENES
GO Biological Process (4): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357), positive regulation of biosynthetic process (GO:0009891), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), nuclear lumen (GO:0031981)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 2 |
| transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| negative regulation of DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| biosynthetic process | 1 |
| regulation of biosynthetic process | 1 |
| positive regulation of metabolic process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nucleus | 1 |
| intracellular organelle lumen | 1 |
Protein interactions and networks
STRING
682 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF182 | ARAF | P07557 | 853 |
| ZNF182 | TIMP1 | P01033 | 695 |
| ZNF182 | TBC1D25 | Q3MII6 | 587 |
| ZNF182 | OR10H2 | O60403 | 506 |
| ZNF182 | CXorf38 | Q8TB03 | 491 |
| ZNF182 | SPACA5B | Q96QH8 | 446 |
| ZNF182 | C1GALT1C1L | P0DN25 | 443 |
| ZNF182 | WDR13 | Q9H1Z4 | 419 |
| ZNF182 | ZC4H2 | Q9NQZ6 | 411 |
| ZNF182 | POGZ | Q7Z3K3 | 399 |
| ZNF182 | RNF113A | O15541 | 395 |
| ZNF182 | MTMR11 | A4FU01 | 385 |
| ZNF182 | LIPT1 | Q9Y234 | 369 |
| ZNF182 | ABRACL | Q9P1F3 | 367 |
| ZNF182 | DYM | Q7RTS9 | 359 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC9A8 | ZNF432 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC9A8 | AP1G1 | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM54 | ZNF182 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): ZNF182 (Affinity Capture-MS), ZNF182 (Two-hybrid), ZNF182 (Affinity Capture-MS), ZNF182 (Affinity Capture-MS), ZNF182 (Affinity Capture-MS), ZNF182 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
44 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 27 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 394569 | GRCh37/hg19 Xp11.23(chrX:47705458-47863717)x3 | Likely pathogenic |
SpliceAI
393 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:47977795:CTT:C | acceptor_gain | 1.0000 |
| X:47977796:TT:T | acceptor_gain | 0.9900 |
| X:47977798:C:CC | acceptor_gain | 0.9900 |
| X:47983280:CT:C | donor_loss | 0.9900 |
| X:47983283:AC:A | donor_gain | 0.9900 |
| X:47983283:ACCC:A | donor_loss | 0.9900 |
| X:47983284:CC:C | donor_gain | 0.9900 |
| X:47983284:CCCA:C | donor_gain | 0.9900 |
| X:47983408:GCCCC:G | acceptor_loss | 0.9900 |
| X:47983411:CCTG:C | acceptor_loss | 0.9900 |
| X:47983412:C:A | acceptor_loss | 0.9900 |
| X:47983413:T:A | acceptor_loss | 0.9900 |
| X:47988520:ATACC:A | donor_loss | 0.9900 |
| X:47988521:TACCT:T | donor_loss | 0.9900 |
| X:47988522:ACCTG:A | donor_loss | 0.9900 |
| X:47988523:C:CG | donor_loss | 0.9900 |
| X:47977797:TC:T | acceptor_loss | 0.9800 |
| X:47977798:C:T | acceptor_loss | 0.9800 |
| X:47977799:T:C | acceptor_loss | 0.9800 |
| X:47982942:CACTT:C | donor_loss | 0.9800 |
| X:47982943:ACTTA:A | donor_loss | 0.9800 |
| X:47982944:CTTAC:C | donor_loss | 0.9800 |
| X:47982945:TTA:T | donor_loss | 0.9800 |
| X:47982946:TA:T | donor_loss | 0.9800 |
| X:47983409:CCC:C | acceptor_gain | 0.9800 |
| X:47983410:CCC:C | acceptor_gain | 0.9800 |
| X:47983412:C:CC | acceptor_gain | 0.9800 |
| X:47983414:G:C | acceptor_loss | 0.9800 |
| X:47988519:CATA:C | donor_loss | 0.9800 |
| X:47983283:A:AC | donor_gain | 0.9700 |
AlphaMissense
4129 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:47977106:G:C | F327L | 0.999 |
| X:47977106:G:T | F327L | 0.999 |
| X:47977108:A:G | F327L | 0.999 |
| X:47976417:A:G | L557P | 0.998 |
| X:47976434:A:C | F551L | 0.998 |
| X:47976434:A:T | F551L | 0.998 |
| X:47976436:A:G | F551L | 0.998 |
| X:47976765:T:G | Q441P | 0.998 |
| X:47976825:T:G | Q421P | 0.998 |
| X:47976854:G:C | F411L | 0.998 |
| X:47976854:G:T | F411L | 0.998 |
| X:47976856:A:G | F411L | 0.998 |
| X:47977190:G:C | F299L | 0.998 |
| X:47977190:G:T | F299L | 0.998 |
| X:47977192:A:G | F299L | 0.998 |
| X:47977242:C:G | R282P | 0.998 |
| X:47977274:A:C | F271L | 0.998 |
| X:47977274:A:T | F271L | 0.998 |
| X:47977276:A:G | F271L | 0.998 |
| X:47976266:A:C | F607L | 0.997 |
| X:47976266:A:T | F607L | 0.997 |
| X:47976268:A:G | F607L | 0.997 |
| X:47976350:G:C | F579L | 0.997 |
| X:47976350:G:T | F579L | 0.997 |
| X:47976352:A:G | F579L | 0.997 |
| X:47976501:A:G | L529P | 0.997 |
| X:47976518:G:C | F523L | 0.997 |
| X:47976518:G:T | F523L | 0.997 |
| X:47976520:A:G | F523L | 0.997 |
| X:47976602:A:C | F495L | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000073254 (X:47994559 T>A), RS1000119540 (X:47986985 C>T), RS1000209631 (X:47975562 T>C), RS1000475562 (X:47975880 T>C,G), RS1000683804 (X:47997146 G>A), RS1000746958 (X:47996693 A>T), RS1001218577 (X:47978066 C>T), RS1001329240 (X:47988849 G>C), RS1001479749 (X:47978628 C>T), RS1001752104 (X:47998823 T>C), RS1002182059 (X:47991524 C>A), RS1002441709 (X:47980362 A>C,T), RS1002684782 (X:48001176 T>C), RS1002703035 (X:47991129 A>G), RS1002753505 (X:48000618 A>G)
Disease associations
OMIM: gene MIM:314993 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 3 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Estradiol | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Lead | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Dronabinol | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.